Gene · 8894
Papers3,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human transcriptional signature of protection after Plasmodium falciparum immunization and infectious challenge via mosquito bites. | Hum Vaccin Immunother | 2023 | 38010150 | PubTator, text mining | PubMed |
| The Diverse Genomic Landscape of Diamond-Blackfan Anemia: Two Novel Variants and a Mini-Review. | Children (Basel) | 2023 | 38002903 | PubTator, text mining | PubMed |
| Inhibition of EIF2α Dephosphorylation Decreases Cell Viability and Synergizes with Standard-of-Care Chemotherapeutics in Head and Neck Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | 38001610 | PubTator, text mining | PubMed |
| Mayaro virus pathogenesis and immunity in rhesus macaques. | PLoS Negl Trop Dis | 2023 | 37983245 | PubTator, text mining | PubMed |
| Spatially distinct molecular patterns of gene expression in idiopathic pulmonary fibrosis. | Respir Res | 2023 | 37978501 | PubTator, text mining | PubMed |
| Classification, function, and advances in tsRNA in non-neoplastic diseases. | Cell Death Dis | 2023 | 37973899 | PubTator, text mining | PubMed |
| PLP2 Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme. | Pharmgenomics Pers Med | 2023 | 37964785 | PubTator, text mining | PubMed |
| Cannflavins A and B with Anti-Ferroptosis, Anti-Glycation, and Antioxidant Activities Protect Human Keratinocytes in a Cell Death Model with Erastin and Reactive Carbonyl Species. | Nutrients | 2023 | 37960218 | PubTator, text mining | PubMed |
| Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies. | Cancers (Basel) | 2023 | 37958442 | PubTator, text mining | PubMed |
| Characterizing the extracellular vesicle proteomic landscape of the human airway using in vitro organotypic multi-cellular models. | iScience | 2023 | 37920665 | PubTator, text mining | PubMed |
| Engineered small extracellular vesicles as a novel platform to suppress human oncovirus-associated cancers. | Infect Agent Cancer | 2023 | 37915098 | PubTator, text mining | PubMed |
| Establishment of a novel ER-stress induced myopia model in mice. | Eye Vis (Lond) | 2023 | 37907982 | PubTator, text mining | PubMed |
| In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future. | Vaccines (Basel) | 2023 | 37897003 | PubTator, text mining | PubMed |
| The intrinsically disordered region of eIF5B stimulates IRES usage and nucleates biological granule formation. | Cell Rep | 2023 | 37862172 | PubTator, text mining | PubMed |
| An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives. | Front Pharmacol | 2023 | 37860119 | PubTator, text mining | PubMed |
| A highly efficient human cell-free translation system. | RNA | 2023 | 37793791 | PubTator, text mining | PubMed |
| Poly(2-oxazoline)/saRNA Polyplexes for Targeted and Nonviral Gene Delivery. | Biomacromolecules | 2023 | 37792545 | PubTator, text mining | PubMed |
| Double-edged sword of JAK/STAT signaling pathway in viral infections: novel insights into virotherapy. | Cell Commun Signal | 2023 | 37784164 | PubTator, text mining | PubMed |
| The Helix-Loop-Helix motif of human EIF3A regulates translation of proliferative cellular mRNAs. | PLoS One | 2023 | 37768948 | PubTator, text mining | PubMed |
| Insights into Repeated Renal Injury Using RNA-Seq with Two New RPTEC Cell Lines. | Int J Mol Sci | 2023 | 37762531 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8894/papers?page=7